About D-PHENYLALANINE

About Talc
31 7 月, 2021
Knowledge about sodium bicarbonate
21 8 月, 2021

About D-PHENYLALANINE

The scientific name of phenylalanine is α-amino-β-phenyl propionic acid, which is a kind of α-amino acid, including L-type, D-type, and racemic DL-type, among which L-type is one of the essential amino acids for the human body. Phenylalanine is a new amino acid first discovered by Schulze and Barbieri in the late 1880s, isolated from lupin seedlings, and proposed an empirical chemical formula of C9H11NO2. Erlenmeyer and Lipp successfully synthesized phenylalanine by chemical synthesis for the first time in 1882, but they did not explore its spatial configuration. Then Fischer accidentally isolated phenylalanine when he hydrolyzed casein with hydrochloric acid in 1901. Since then, his research on phenylalanine has been more in-depth. D-Phenylalanine is a kind of α-amino acid. Its physical state is a white powder or white crystalline solid at room temperature. It has a melting point of 283°C, an isoelectric point (25°C) of 5.48, and solubility of 27g/L in water at 25°C. Slightly soluble in methanol, ethanol, insoluble in ether, etc., specific rotation [α]25D=+34.5(c=1.0, H2O). Like other D-amino acids, D-phenylalanine is a very important chiral intermediate in organic synthesis, new drug development, synthesis of peptide compounds, etc., and because of the special structure and activity of D-phenylalanine itself Sex, more and more people pay more and more attention.

Application


Studies have found that L-phenylalanine is widely present in nature and is one of the essential amino acids for the human body. It is mainly found in various proteins, such as fibrin and hemoglobin. L-phenylalanine is found in it. L-phenylalanine also plays an important role in the secretion of thyroid hormones, hair, and skin melanin. As an unnatural amino acid, D-phenylalanine can not directly participate in the synthesis of human protein. Its physical and chemical properties are similar to those of L-phenylalanine, and D-phenylalanine is due to its special chiral structure and biological activity. It has incomparable application value of L-phenylalanine in the fields of industry, agriculture, food, medicine, and pesticide. In light industrial production, the application of unnatural amino acids to the production of cosmetics to improve and enhance product quality and performance has become more and more common. For example, some manufacturers add amino acids to facial cleansers. Compared with the past, the pH of such products is closer to human skin. Therefore, it is gentle and skin-friendly, without irritation, and can protect the skin. In the biochemical reagent industry, since D-amino acids are not involved in human metabolism, the half-life of antibiotic drugs with D-amino acid structure in human metabolism is significantly longer than that of drugs with L-amino acid structure, so there is more information about D-amino acid derivatives. The demand for sex drug research is also rising. Among them, N-test-butoxy carbonyl-D-phenylalanine (BOC-D-phenylalanine), fluorenylmethyloxycarbonyl-D-phenylalanine (FMOC-D-phenylalanine), and other biochemical reagents are all made of D-phenylalanine Amino acid is a substrate for derivatization and synthesis.
At present, D-phenylalanine is often seen active in the fields of medicine and pesticides. D-phenylalanine can prevent the activity of enkephalin kinase and inhibit the decomposition of enkephalin, so it is applied to enkephalin and inhibitors of enkephalin as diuretics and anti-addiction drugs. Drugs in which D-phenylalanine is involved in the synthesis can also be used to prevent and treat Marek's disease. D-phenylalanine is also partly used in drugs for the treatment of hypertension and diabetes. D-phenylalanine is also widely used as a raw material for the treatment of arthritis, depression, and other drugs. In addition, many other important compounds require D-phenylalanine to prepare, such as pyrrolidone peptide compounds, carrier α-amino phosphate for biofilm transmission, AIDS (HIV-1) protease inhibitors, Bombesin receptor antagonist for the treatment of sexual dysfunction, new NEP and ACE inhibitor hydroxamic acid derivatives, and N-(amido-alkyl)-4-3-hydroxybenzene for detoxification Piperidine and its derivatives, growth inhibitor analogs for the treatment of gastrinoma, drugs for the prevention and treatment of arteriosclerosis, analgesics, peptide-based antithrombotics, neurological disorders, metalloproteinase inhibitors, anti- D-phenylalanine is used in fungal medicine and organotin pesticides. At present, D-phenylalanine is mainly used as the raw material of the famous anti-diabetic drug Naglena and the anti-tumor drug Best in.


Preparation


In the past more than a century, the production and preparation methods of amino acids have always been one of the research hotspots. At present, the research on the production method of L-phenylalanine has been relatively mature, mainly including the direct fermentation method, enzymatic method, and chemical synthesis method. However, D-phenylalanine is an unnatural amino acid that is difficult to obtain from natural products, nor can it be prepared by direct fermentation. The chemical synthesis production process is complicated and requires high equipment and is difficult to produce on a large scale. With the continuous expansion of the application of D-phenylalanine in light industry, medicine, pesticides, food, and other fields, the market demand will also continue to increase. Therefore, we are looking for D-phenylalanine with a simple process and cheap raw materials. The preparation method of acid has become one of the research directions of chemists. The current methods for preparing D-phenylalanine mainly include resolution, biological, and asymmetric chemical synthesis. Among them, asymmetric synthesis, especially asymmetric catalytic hydrogenation, has shown broad prospects.
1) Split method
Racemic phenylalanine is a compound composed of L-phenylalanine and D-phenylalanine mixed in equal amounts. Their physical and chemical properties are the same, but the optical rotation is opposite to each other. Therefore, it is difficult to separate the racemate into a single configuration of phenylalanine with general physical methods, and special methods must be used to separate it. Using 35-dinitrobenzene substituted β-cyclodextrin as the stationary phase, the D and L-amino acids were resolved by chiral thin-layer chromatography. The experiment found that phenylalanine was due to the presence of the benzene ring structure. It has a strong effect on the chiral stationary phase, which makes the racemic phenylalanine appear with different physical properties, thus obtaining a better resolution effect. However, the splitting agent used in this method is expensive, consumes a lot, and splits the efficiency is not high, so it is difficult to prepare for large-scale production use. The penicillin acylase was immobilized, and then the racemic phenylalanine derivatives N-phenyl acetyl-D and L-phenylalanine were resolved to obtain crude N-phenyl acetyl-D-phenylalanine. After removing the protective group, the cation resin exchange desalting process is used to obtain D-phenylalanine with an optical purity of 91.4% and a yield of 67%. This method also has disadvantages such as low efficiency, high energy consumption, low yield, and low product optical purity. There are also related literature reports that the resolution of racemic phenylalanine with chemical reagents dioxaphosphine compounds, but the resolution rate is less than 36%.
2) Biological Law
The biological method has been widely concerned and highly valued in the field of amino acid production due to its relatively mild reaction conditions and high stereoselectivity. There are also many literature reports on the use of biological methods to produce D-phenylalanine. The D-configuration amino acid acylase is induced by two special bacteria. This enzyme can convert N-acetyl-D-phenylalanine into D-phenylalanine, and the highest yield can reach 83.1%. The optical purity of the product has not been reported. Although this method is feasible, it is limited to laboratory research and does not yet have the conditions for industrial production. According to related reports, Japan Zhongsheng Chemical Company recombined D-hydantoins and N-carbamylamino acid into Escherichia coli using genetic engineering and successfully expressed it, and extracted the crude enzyme for immobilization to produce D-phenylalanine. Good experimental results have been achieved. At present, Japanese companies such as Zhongshenghua have improved the strains through genetic engineering methods, but there are still disadvantages in the production of D-phenylalanine, such as low substrate concentration, long conversion time, and low conversion rate.
3) Asymmetric synthesis method
Asymmetric synthesis generally refers to a type of reaction that uses special chemical reagents, solvents, catalysts, or physical factors to convert latent units into chiral units to produce unequal amounts of stereoisomeric products. The asymmetric synthesis reaction has developed rapidly in recent years and has achieved remarkable results. It has become one of the most active research fields in organic chemistry. There are many reports on the use of this method to synthesize phenylalanine. In 1988, it was reported that D-camphor one imine condensed with D-camphor and glycine butyl vinegar was used as a chiral synthon. D-phenylalanine was synthesized enantioselectively through asymmetric synthesis. The optical purity of the product was The ee value reaches 95%, and the yield reaches 92.7%. However, this method requires more stringent reaction conditions, high energy consumption, and high cost, and is only suitable for small-scale synthesis research in the laboratory. Another effective method for the asymmetric synthesis of α-amino acids is to use rhodium-catalyzed tandem 1,4-addition protonation (Michael type addition reaction) to catalyze α, β-dehydroamino acids. The organic metal reagent is used to react the amido acrylate in the presence of a rhodium catalyst and a chiral phosphine ligand to obtain the corresponding α-chiral amino acid derivative. The ee value of the phenylalanine derivative is 89.5% and is in the L configuration. The method is simple to operate, but the reaction uses too many rhodium catalysts and chiral phosphine ligands, the cost is too high and the optical purity of the product is not high, and it only stays in the laboratory research stage, and there is no production report using this method.